187 related articles for article (PubMed ID: 32891180)
1. An anti-perfringolysin O monoclonal antibody cross-reactive with streptolysin O protects against streptococcal toxic shock syndrome.
Matsumura T; Nishiyama A; Aiko M; Ainai A; Ikebe T; Chiba J; Ato M; Takahashi Y
BMC Res Notes; 2020 Sep; 13(1):419. PubMed ID: 32891180
[TBL] [Abstract][Full Text] [Related]
2. Single-chain variable fragment (scFv) targeting streptolysin O controls group A Streptococcus infection.
Aikawa C; Kawashima K; Fukuzaki C; Nakakido M; Murase K; Nozawa T; Tsumoto K; Nakagawa I
Biochem Biophys Res Commun; 2021 Aug; 566():177-183. PubMed ID: 34129965
[TBL] [Abstract][Full Text] [Related]
3. Structural studies of Streptococcus pyogenes streptolysin O provide insights into the early steps of membrane penetration.
Feil SC; Ascher DB; Kuiper MJ; Tweten RK; Parker MW
J Mol Biol; 2014 Feb; 426(4):785-92. PubMed ID: 24316049
[TBL] [Abstract][Full Text] [Related]
4. [Properties of extracellular products produced by group A streptococci isolated from patient with streptococcal toxic shock syndrome].
Suzuki J; Yoshihara E; Kobayashi S
Kansenshogaku Zasshi; 1997 Mar; 71(3):273-8. PubMed ID: 9128015
[TBL] [Abstract][Full Text] [Related]
5. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections.
Müller-Alouf H; Geoffroy C; Geslin P; Bouvet A; Felten A; Günther E; Ozegowski JH; Alouf JE
Zentralbl Bakteriol; 1997 Oct; 286(3):421-33. PubMed ID: 9361388
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pathogenic factors expressed by group A Streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever.
Shiseki M; Miwa K; Nemoto Y; Kato H; Suzuki J; Sekiya K; Murai T; Kikuchi T; Yamashita N; Totsuka K; Ooe K; Shimizu Y; Uchiyama T
Microb Pathog; 1999 Oct; 27(4):243-52. PubMed ID: 10502465
[TBL] [Abstract][Full Text] [Related]
7. [Properties of extracellular products produced by group A streptococci isolated from patients with streptococcal toxic shock syndrome].
Suzuki J; Matsubuchi S; Yoshihara E; Kobayashi S; Okamura K; Okuda T; Okazaki M; Furuya N; Uchimura H; Tokunaga T; Shimazaki S
Kansenshogaku Zasshi; 1997 Dec; 71(12):1187-92. PubMed ID: 9483877
[TBL] [Abstract][Full Text] [Related]
8. Intracellular Group A
Nozawa T; Iibushi J; Toh H; Minowa-Nozawa A; Murase K; Aikawa C; Nakagawa I
mBio; 2021 Feb; 12(1):. PubMed ID: 33563838
[TBL] [Abstract][Full Text] [Related]
9. Streptolysin O and NAD-glycohydrolase prevent phagolysosome acidification and promote group A Streptococcus survival in macrophages.
Bastiat-Sempe B; Love JF; Lomayesva N; Wessels MR
mBio; 2014 Sep; 5(5):e01690-14. PubMed ID: 25227466
[TBL] [Abstract][Full Text] [Related]
10. Specificity of streptolysin O in cytolysin-mediated translocation.
Meehl MA; Caparon MG
Mol Microbiol; 2004 Jun; 52(6):1665-76. PubMed ID: 15186416
[TBL] [Abstract][Full Text] [Related]
11. Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates.
Ikebe T; Ato M; Matsumura T; Hasegawa H; Sata T; Kobayashi K; Watanabe H
PLoS Pathog; 2010 Apr; 6(4):e1000832. PubMed ID: 20368967
[TBL] [Abstract][Full Text] [Related]
12. Binding of NAD
Velarde JJ; O'Seaghdha M; Baddal B; Bastiat-Sempe B; Wessels MR
mBio; 2017 Sep; 8(5):. PubMed ID: 28900022
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization and antibiotic resistance of Streptococcus dysgalactiae subspecies equisimilis isolated from patients with streptococcal toxic shock syndrome.
Ikebe T; Okuno R; Sasaki M; Kanda Y; Otsuka H; Kawahara R; Ohya H; Suzuki M; Uchida K; Nihonmatsu H; Ohnishi M;
J Infect Chemother; 2018 Feb; 24(2):117-122. PubMed ID: 29107650
[TBL] [Abstract][Full Text] [Related]
14. Human polyspecific immunoglobulin attenuates group A streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model.
Tarnutzer A; Andreoni F; Keller N; Zürcher C; Norrby-Teglund A; Schüpbach RA; Zinkernagel AS
Clin Microbiol Infect; 2019 Apr; 25(4):512.e7-512.e13. PubMed ID: 30025835
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism behind streptococcus toxic shock-like syndrome onset--immune evasion and bacterial properties].
Ikebe T; Ato M; Kobayashi K; Watanabe H
Kansenshogaku Zasshi; 2009 Sep; 83(5):485-9. PubMed ID: 19860247
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism to cause streptococcal toxic-shock syndrome].
Miyoshi-Akiyama T; Uchiyama T
Rinsho Byori; 2000 Jul; 48(7):580-7. PubMed ID: 11051781
[TBL] [Abstract][Full Text] [Related]
17. Natural mutation in the regulatory gene (srrG) influences virulence-associated genes and enhances invasiveness in Streptococcus dysgalactiae subsp. equisimilis strains isolated from cases of streptococcal toxic shock syndrome.
Ikebe T; Otsuka H; Chiba K; Kazawa Y; Yamaguchi T; Okuno R; Date Y; Sasaki M; Isobe J; Ohnishi M; Akeda Y
EBioMedicine; 2022 Jul; 81():104133. PubMed ID: 35779495
[TBL] [Abstract][Full Text] [Related]
18. Incompetence of neutrophils to invasive group A streptococcus is attributed to induction of plural virulence factors by dysfunction of a regulator.
Ato M; Ikebe T; Kawabata H; Takemori T; Watanabe H
PLoS One; 2008; 3(10):e3455. PubMed ID: 18941623
[TBL] [Abstract][Full Text] [Related]
19. Streptolysin O and its co-toxin NAD-glycohydrolase protect group A Streptococcus from Xenophagic killing.
O'Seaghdha M; Wessels MR
PLoS Pathog; 2013; 9(6):e1003394. PubMed ID: 23762025
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization and antimicrobial resistance of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2013 to 2018.
Ikebe T; Okuno R; Kanda Y; Sasaki M; Yamaguchi T; Otsuka H; Kazawa Y; Suzuki M; Ohya H; Uchida K; Ohnishi M;
Int J Med Microbiol; 2021 Apr; 311(3):151496. PubMed ID: 33756191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
